MobiHealth News August 28, 2025
Transcend Plus includes AI-enabled clinical applications and FDA-cleared enhancements.
Health technology company Royal Philips announced the release of Transcend Plus, its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems.
Transcend Plus features FDA-cleared 2D- and 3D-image quality enhancements, as well as a suite of AI-enabled clinical applications.
According to the company, Transcend Plus improves sharpness, contrast and detail in 2D and 3D imaging, including the latest FDA-cleared enhancements for EPIQ CVx and Affiniti CVx.
In addition, the upgrades support visualization of cardiac anatomy and function, allowing diagnostic confidence even in complicated or technically challenging cases, according to the company.
The update also includes a new 2D Auto EF Advanced feature that expands AI capabilities for contrast images, considered...
Today's Sponsors
Today's Sponsor